Please ensure Javascript is enabled for purposes of website accessibility
Prosper Junior Bakiny

Prosper Junior Bakiny


A Fool since 2019, Prosper's writing focuses primarily on the healthcare sector. Passionate about teaching and learning, he enjoys helping others make better decisions about their finances -- and enjoys it just as much when they return the favor. In his free time, you'll find him curling up with a good book or doing math.

Recent articles


Why Novavax and Endo International Stocks Are Rising Today

The two companies signed a manufacturing agreement.


Why Inovio Pharmaceuticals Stock Is Down Today

Short-seller Citron Research strikes again.


Here's My Top Coronavirus Vaccine Stock to Buy

Don't just look at this company's experimental COVID-19 vaccine; there are other reasons to consider investing in it.


Is Jazz Pharmaceuticals a Top Stock to Buy Now?

Despite a poor performance of late, this biotech stock could bounce back.


2 Healthcare Stocks That Are Better Growth Buys Than Tesla

These industry giants are positioned to deliver massive gains in the long run, far beyond that of the electric vehicle pioneer.


Why Arrowhead Pharmaceuticals Stock Is Soaring Today

The company reported positive interim data from a clinical trial.


Is Vaxart a Good Coronavirus Stock to Buy?

If you missed the biotech's explosive gains earlier this year, it may not be too late to get in on the act.


Is Biogen Stock a Buy?

The biotech is facing several headwinds. Should investors get on board anyway?


Why Inovio Pharmaceuticals Stock Is Jumping Today

No news is good news for this biotech company.


AstraZeneca Shows the Risk of Investing in Coronavirus Vaccine Stocks

Investors got a not-so-sweet reminder of the difficulties and risks of clinical trials.


Is Novavax Stock a Buy?

After a recent pullback, this biotech company may be worth a second look.


Why Evofem Biosciences Stock Is Plunging Today

The company's CEO made a noteworthy move.


2 Top Dividend Stocks to Buy in a Stock Market Crash

These two pharma giants are unlikely to cut their dividend payments during the next market correction.


Why Athenex Stock Is Down Today

The company announced the pricing of a public offering of common stock.


Why iBio Stock Is Soaring Today

The company is advancing its most-promising vaccine candidate for the novel coronavirus.


Has Inovio Stock Peaked?

After a furious rally during the first half of the year, Inovio's stock has cooled off significantly. Can the company turn things around?


Is bluebird bio Stock a Buy?

bluebird bio hasn't performed well in the stock market of late. Do the biotech's recent woes make this a good opportunity for investors to buy its shares?


2 Healthcare Stocks That Are Better Value Buys Than Apple

If you think Apple's valuation is too steep, check out these two pharma giants.


Why Albireo Pharma Stock Is Skyrocketing Today

The company reported positive data from a clinical trial.


2 Cannabis Stocks You'll Regret Not Buying During This Market Correction

Both have struggled over the past year, but there are reasons to expect their stocks could stage strong comebacks over the longer term.